MarketPeel
Insider Trading Intelligence
Pricing
…
JL

James Woodruff Lillie

MPLT
CHIEF SCIENTIFIC OFFICER · MAPLIGHT THERAPEUTICS, INC. · CIK 0001728746
FILING MIX · LIFETIME16%/84%
BUYS
4
SELLS
21
TOTAL VALUE
$3.37M
COMPANIES
1
ACTIVE SINCE
Oct 2025
HOLDINGS NOW
202,380
AVG SELL PX
$23.69
TRADE KIND
SHOWING 25 / 25
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 36 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by James Woodruff Lillie, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+0.00%+6.18%+1.93%+4.25%+2.21%—
14d12+0.00%+6.17%+2.86%+3.66%-1.01%—
30d12+8.33%+2.59%+4.13%-2.14%-2.71%—
60d12+0.00%+21.32%+3.58%+17.74%+21.54%—
90d12+75.00%-30.78%+4.66%-35.44%-56.23%—
180d12(12 pending)——————
1y12(12 pending)——————
2y12(12 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MPLT · 202,380 shares · as of Aug 3, 2026
074,716149,431224,147298,8622026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2025
2026
2026
2026
FLOW · 4 buys / 21 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
22,082$12.54$276.9K202,380Aug 3, 2026Aug 4, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,077$37.90$78.7K224,462Jul 17, 2026Jul 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
12$37.96$456226,539Jul 16, 2026Jul 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,009$36.45$182.6K230,077Jul 16, 2026Jul 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,526$37.26$131.4K226,551Jul 16, 2026Jul 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,238$36.00$80.6K240,491Jul 15, 2026Jul 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,393$36.99$199.5K235,098Jul 15, 2026Jul 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
12$37.54$450235,086Jul 15, 2026Jul 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
721$28.28$20.4K242,729May 7, 2026May 11, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,390$28.04$235.3K259,871May 6, 2026May 6, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
16,421$29.13$478.3K243,450May 6, 2026May 6, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
963$29.00$27.9K268,261May 5, 2026May 6, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,132$28.12$284.9K269,224May 5, 2026May 6, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,250$27.50$254.4K285,907May 4, 2026May 6, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,526$28.37$156.8K280,381May 4, 2026May 6, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
320$29.56$9.5K280,061May 4, 2026May 6, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
705$30.08$21.2K279,356May 4, 2026May 6, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,097$27.49$57.6K295,157Apr 16, 2026Apr 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
686$27.01$18.5K297,254Apr 16, 2026Apr 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,730$26.82$46.4K297,940Apr 15, 2026Apr 17, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,395——31,395Feb 5, 2026Feb 9, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,730——298,862Feb 5, 2026Feb 9, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Scientific Officer
45,055$17.98$810.1K291,132Jan 27, 2026Jan 29, 2026 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,539——32,539Oct 27, 2025Oct 28, 2025 ↗View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
132,023——132,023Oct 27, 2025Oct 28, 2025 ↗View →
Other insiders · MPLT
Loading peer insiders…
About this filer
CIK 0001728746
ROLE
Chief Scientific Officer
PRIMARY
MPLT
COMPANIES
1
ACTIVE SINCE
Oct 2025
MARKETPEEL · /INSIDER/0001728746DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback